Recent advances in SREBF1 research have focused on understanding its regulation at the molecular level and its role in metabolic diseases. Techniques such as CRISPR-Cas9 gene editing and RNA sequencing have been employed to elucidate the pathways regulated by SREBF1 and to identify potential therapeutic targets for metabolic disorders.